Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
coronavirus
amgen
archive
big data
biotechnology
boston blog main
boston top stories
cholesterol
clinical trials
daniel kivatinos
data
health
healthbeat 2014
healthcare
inclisiran
ldl
life sciences
mark timney
mt sinai hospital
national blog main
national top stories
new york
new york blog main
new york top stories
pcsk9
peter wijngaard
praluent
prashant vaishnava
regeneron pharmaceuticals
repatha
san francisco blog main
san francisco top stories
sanofi
the medicines co.
What
big
4
×
drug
4
×
medicine
4
×
ceo
covid
new
treatment
aces
addressed
analytics
announced
answers
antibody
beginning
certain
change
cholesterol
community
coronavirus
cost
cov
data
determining
developed
diseases
doses
early
flexible
frequency
gilead
given
guest
hasten
hospitalized
hospitals
idea
inclisiran
indicated
insights
key
Language
unset
Current search:
big
×
drug
×
medicine
×
@slashgear.com
3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@technologyreview.com
3 years ago
A trial is under way of the first new antibody medicine developed to treat covid-19
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@venturebeat.com
9 years ago
How big data is beginning to change how medicine works
